Total Payments
$2,471
2024 Payments
$475.29
Companies
32
Transactions
171
Medicare Patients
3,890
Medicare Billing
$433,733
Payment Breakdown by Category
Food & Beverage$2,436 (98.6%)
Education$34.91 (1.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,436 | 168 | 98.6% |
| Education | $34.91 | 3 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $340.26 | 23 | $0 (2024) |
| Amgen Inc. | $325.48 | 20 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $313.80 | 18 | $0 (2024) |
| PFIZER INC. | $249.95 | 21 | $0 (2022) |
| GlaxoSmithKline, LLC. | $164.55 | 12 | $0 (2024) |
| Allergan Inc. | $159.77 | 10 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $117.16 | 9 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $105.92 | 8 | $0 (2022) |
| Merck Sharp & Dohme LLC | $89.23 | 6 | $0 (2022) |
| AbbVie Inc. | $61.58 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $475.29 | 26 | AstraZeneca Pharmaceuticals LP ($140.77) |
| 2023 | $158.50 | 10 | Lilly USA, LLC ($44.24) |
| 2022 | $221.37 | 15 | Lilly USA, LLC ($76.27) |
| 2021 | $290.11 | 20 | Lilly USA, LLC ($57.29) |
| 2020 | $238.04 | 19 | AstraZeneca Pharmaceuticals LP ($39.93) |
| 2019 | $312.26 | 25 | PFIZER INC. ($148.70) |
| 2018 | $435.73 | 31 | Amgen Inc. ($103.56) |
| 2017 | $339.48 | 25 | Allergan Inc. ($84.21) |
All Payment Transactions
171 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: Respiratory | ||||||
| 11/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/26/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: Diabetes | ||||||
| 10/21/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: Inflammation | ||||||
| 09/30/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: Bone Health | ||||||
| 09/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $26.50 | General |
| Category: RESPIRATORY | ||||||
| 09/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: Inflammation | ||||||
| 08/20/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: Endocrinology | ||||||
| 07/28/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: Diabetes | ||||||
| 07/22/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Inflammation | ||||||
| 07/01/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: Respiratory | ||||||
| 06/11/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: Biological | ||||||
| 06/03/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: Inflammation | ||||||
| 05/29/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Diabetes | ||||||
| 05/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: RESPIRATORY | ||||||
| 05/14/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: Obesity | ||||||
| 05/03/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Respiratory | ||||||
| 03/30/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Diabetes | ||||||
| 03/25/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Bone Health | ||||||
| 03/19/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Biological | ||||||
| 03/04/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Education | In-kind items and services | $11.56 | General |
| Category: Respiratory | ||||||
| 02/27/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Diabetes | ||||||
| 02/13/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: PSYCHIATRY | ||||||
| 02/07/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 736 | 1,680 | $220,456 | $102,677 |
| 2022 | 3 | 686 | 1,525 | $172,788 | $94,054 |
| 2021 | 7 | 1,183 | 1,681 | $184,964 | $106,960 |
| 2020 | 19 | 1,285 | 2,104 | $234,354 | $130,042 |
Total Patients
3,890
Total Services
6,990
Medicare Billing
$433,733
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 431 | 1,277 | $148,763 | $78,511 | 52.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 188 | 245 | $19,011 | $10,925 | 57.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 38 | 74 | $17,868 | $4,381 | 24.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 28 | 29 | $19,585 | $3,781 | 19.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 30 | 34 | $5,542 | $3,020 | 54.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 21 | 21 | $9,687 | $2,059 | 21.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 442 | 1,200 | $140,862 | $74,723 | 53.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 176 | 241 | $18,075 | $10,450 | 57.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 68 | 84 | $13,851 | $8,882 | 64.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 406 | 678 | $79,554 | $50,286 | 63.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 316 | 464 | $52,896 | $28,182 | 53.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 176 | 222 | $17,294 | $11,082 | 64.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 74 | 84 | $11,676 | $6,217 | 53.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 46 | 51 | $8,631 | $5,384 | 62.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 109 | 124 | $10,292 | $4,538 | 44.1% |
| 99304 | Initial nursing facility visit, typically 25 minutes per day | Facility | 2021 | 13 | 15 | $3,375 | $982.88 | 29.1% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2021 | 16 | 16 | $800.00 | $201.60 | 25.2% |
| 82272 | Stool analysis for blood, by peroxidase activity | Office | 2021 | 13 | 13 | $208.00 | $54.99 | 26.4% |
| 81003 | Automated urinalysis test | Office | 2021 | 14 | 14 | $238.00 | $31.50 | 13.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 355 | 862 | $98,278 | $59,575 | 60.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 103 | 244 | $27,639 | $13,546 | 49.0% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2020 | 86 | 87 | $21,750 | $12,330 | 56.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 152 | 200 | $16,600 | $8,503 | 51.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 36 | 87 | $14,703 | $6,986 | 47.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 50 | 56 | $7,784 | $6,041 | 77.6% |
About Dr. Thomas Rogers, MD
Dr. Thomas Rogers, MD is a Internal Medicine healthcare provider based in Campbellsville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/08/2005. The National Provider Identifier (NPI) number assigned to this provider is 1508864117.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Rogers, MD has received a total of $2,471 in payments from pharmaceutical and medical device companies, with $475.29 received in 2024. These payments were reported across 171 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($2,436).
As a Medicare-enrolled provider, Rogers has provided services to 3,890 Medicare beneficiaries, totaling 6,990 services with total Medicare billing of $433,733. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Campbellsville, KY
- Active Since 07/08/2005
- Last Updated 03/07/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1508864117
Products in Payments
- FARXIGA (Drug) $145.85
- MOUNJARO (Drug) $137.01
- AIRSUPRA (Drug) $129.21
- TEFLARO (Drug) $100.76
- ELIQUIS (Drug) $99.60
- JARDIANCE (Drug) $91.27
- TRULICITY (Drug) $85.18
- XARELTO (Drug) $82.36
- Repatha (Biological) $76.14
- EMGALITY (Drug) $74.13
- Aimovig (Biological) $74.09
- Otezla (Drug) $73.35
- CHANTIX (Drug) $65.16
- VRAYLAR (Drug) $61.58
- Prolia (Biological) $51.80
- EVENITY (Biological) $50.10
- Trintellix (Drug) $49.70
- DALVANCE (Drug) $45.18
- ANORO ELLIPTA (Drug) $43.17
- JANUVIA (Drug) $42.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Campbellsville
Dr. David Montgomery, Md, MD
Internal Medicine — Payments: $1,558
Internal Medicine $1,558
William Feltner, D.o, D.O
Internal Medicine — Payments: $1,450
Internal Medicine $1,450
Dr. Joel Eade, Md, MD
Internal Medicine — Payments: $730.66
Internal Medicine $730.66
Dr. Stephen Hinton, Md, MD
Internal Medicine — Payments: $658.12
Internal Medicine $658.12
Sean Maynard, Pa-C, PA-C
Internal Medicine — Payments: $453.19
Internal Medicine $453.19
Dr. James Frank, D.o, D.O
Internal Medicine — Payments: $370.47
Internal Medicine $370.47